Skip to main content

Table 5 Multivariate analysis for overall survival including primary tumour extension

From: Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

Marker Hazard Ratio 95% CI P
Sex 1,185 0,49–2.83 0.702
Age 1.108 0.93–1.13 0.390
Breslow thickness 2.530 1.62–3.94 < 0.001
CMC status (0–1 vs ≥2 positive assays) 2.685 1.17–6.49 0.026
  1. CI, confidence interval